HDT 311
Alternative Names: HDT-311Latest Information Update: 02 Aug 2022
At a glance
- Originator HDT Bio
- Class RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Infections
Most Recent Events
- 26 Jul 2022 Early research in Infections in USA (Parenteral), prior to July 2022 (HDT Bio pipeline, July 2022)